Skip to main content
. 2022 May 27;49:101475. doi: 10.1016/j.eclinm.2022.101475

Figure 3.

Fig. 3

(a) – (f): Mucocutaneous manifestations of MIS-C. (a) oral ulcers and sores (b) non suppurative conjunctivitis; (c) Generalized maculopapular desqaumating rash; (d) and (e) Transient erythematous rash; (f) plantar erythema and edema.